Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Montserrat González-Sastre"'
Autor:
Gemma Llauradó, Albert Cano, Lara Albert, Silvia Ballesta, Isabel Mazarico, María-Florencia Luchtenberg, Montserrat González-Sastre, Ana Megía, Rafael Simó, Joan Vendrell, José-Miguel González-Clemente
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0220206 (2019)
OBJECTIVES:Currently used risk scores for type 2 diabetes mellitus (T2DM) clearly underestimate cardiovascular risk in type 1 diabetes (T1DM). Hence, there is a need to develop novel and specific risk-estimation tools for this population. We aimed to
Externí odkaz:
https://doaj.org/article/e00ebb765a2b4539a1c3b777b45a1c2f
Autor:
Gemma Llauradó, Albert Cano, Cristina Hernández, Montserrat González-Sastre, Ato-Antonio Rodríguez, Jordi Puntí, Eugenio Berlanga, Lara Albert, Rafael Simó, Joan Vendrell, José-Miguel González Clemente
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0174640 (2017)
The aim of the study was to develop a novel risk estimation model for predicting silent myocardial ischemia (SMI) in patients with type 1 diabetes (T1DM) and no clinical cardiovascular disease, evaluating the potential role of insulin resistance in s
Externí odkaz:
https://doaj.org/article/ecbab243e9cf443c98a4582e7b43a6ec
Autor:
Gemma Llauradó, Ana Megia, Albert Cano, Olga Giménez-Palop, Inmaculada Simón, Montserrat González-Sastre, Eugenio Berlanga, Sonia Fernández-Veledo, Joan Vendrell, José-Miguel González-Clemente
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0140222 (2015)
To investigate the usefulness of Fibroblast Growth Factor 23 (FGF-23) and vitamin D as possible biomarkers of pre-clinical atherosclerosis, assessed as arterial stiffness (AS), in a group of subjects with type 1 diabetes (T1DM) and no previous cardio
Externí odkaz:
https://doaj.org/article/99d1bde0104b47eeaf14b9030d284dab
Autor:
Sonia Fernández-Veledo, Isabel Mazarico, Joan Vendrell, Laia Martínez, Montserrat González-Sastre, Albert Cano, Gemma Llauradó, Rafael Simó, José-Miguel González-Clemente, Lara Albert, Brenno Astiarraga
Publikováno v:
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Journal of Clinical Medicine
Volume 9
Issue 7
Journal of Clinical Medicine, Vol 9, Iss 2192, p 2192 (2020)
Universitat Autònoma de Barcelona
Journal of Clinical Medicine
Volume 9
Issue 7
Journal of Clinical Medicine, Vol 9, Iss 2192, p 2192 (2020)
Background: We sought to assess the potential of insulin resistance (IR) for estimating cardiovascular disease (CVD) risk in adults with type 1 diabetes (T1DM) according to the scores of the Steno Type 1 Risk Engine (ST1RE). Methods: A total of 179 a
Autor:
María-Florencia Luchtenberg, Ana Megia, Albert Cano, José-Miguel González-Clemente, Rafael Simó, Isabel Mazarico, Joan Vendrell, Montserrat González-Sastre, Silvia Ballesta, Gemma Llauradó, Lara Albert
Publikováno v:
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
PLoS ONE, Vol 14, Iss 9, p e0220206 (2019)
Scientia
PLoS ONE
Universitat Autònoma de Barcelona
PLoS ONE, Vol 14, Iss 9, p e0220206 (2019)
Scientia
PLoS ONE
Steno Type 1 Risk Engine (ST1RE); Arterial stiffness; Type 1 diabetes (T1DM) Motor de Risc Steno Tipus 1; Rigidesa arterial; Diabetis mellitus tipus 1 (DM1) Motor de Riesgo Steno Tipo 1; Rigidez arterial; Diabetes mellitus tipo 1 (DM1) OBJECTIVES: Cu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ed82d70dd314e53557a002caf663df5
https://ddd.uab.cat/record/224078
https://ddd.uab.cat/record/224078
Autor:
Lara Albert Fabregas, José Miguel González-Clemente, Montserrat González-Sastre, Gemma Llauradó, Isabel Mazarico, Albert Cano
Publikováno v:
Endocrine Abstracts.
Autor:
Albert Cano, Ato-Antonio Rodríguez, Eugenio Berlanga, Montserrat González-Sastre, José-Miguel González Clemente, Joan Vendrell, Rafael Simó, Jordi Puntí, Lara Albert, Cristina Hernández, Gemma Llauradó
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 4, p e0174640 (2017)
Plos One
PLoS ONE, Vol 12, Iss 4, p e0174640 (2017)
Plos One
Objectives The aim of the study was to develop a novel risk estimation model for predicting silent myocardial ischemia (SMI) in patients with type 1 diabetes (T1DM) and no clinical cardiovascular disease, evaluating the potential role of insulin resi